(1 - 13 from 16
)
Researchers identify new targets for future CLL therapies
www.news-medical.net
Dec 06, · MDC, Berlin-Buch) and the hematologist Dr. Armin Rehm ... Researchers identify new targets for future CLL therapies Published on December 7,
MDC and Charité Researchers Identify Dendritic Cell Mechanism Driving...
www.mdc-berlin.de
Now the hematologist Dr. Armin Rehm (MDC and Charité – Universitätsmedizin Berlin) and the immunologist Dr. Uta Höpken (MDC) have ...
Why CLL is Most Often Characterized by Relapses after Treatment | MDC...
www.mdc-berlin.de
... Delbrück Center for Molecular Medicine, MDC, Berlin-Buch) and the hematologist Dr. Armin Rehm (MDC and Charité – Universitätsmedizin ...
Survival niche for cancer cells - Physorg | (e) Science News
esciencenews.com
... and Immunogenetics Research Group at the Max Delbrück Center for Molecular Medicine, MDC, Berlin-Buch in the Helmholtz Association) and the hematologist Dr. Armin Rehm
sorted by relevance / date